InnoCan Pharma's total assets for Q1 2025 were $10.82M, an increase of 16.81% from the previous quarter. INNPF total liabilities were $3.93M for the fiscal quarter, a 75.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.